BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gardet A, Zheng TS, Viney JL. Genetic architecture of human fibrotic diseases: disease risk and disease progression. Front Pharmacol 2013;4:159. [PMID: 24391588 DOI: 10.3389/fphar.2013.00159] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Herzog EL, Mathur A, Tager AM, Feghali-Bostwick C, Schneider F, Varga J. Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct? Arthritis Rheumatol 2014;66:1967-78. [PMID: 24838199 DOI: 10.1002/art.38702] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 13.0] [Reference Citation Analysis]
2 Harmanci D, Erkan EP, Kocak A, Akdogan GG. Role of the microRNA-29 family in fibrotic skin diseases. Biomed Rep 2017;6:599-604. [PMID: 28584629 DOI: 10.3892/br.2017.900] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
3 Chadli L, Sotthewes B, Li K, Andersen SN, Cahir-McFarland E, Cheung M, Cullen P, Dorjée A, de Vries-Bouwstra JK, Huizinga TWJ, Fischer DF, DeGroot J, Viney JL, Zheng TS, Aarbiou J, Gardet A. Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients. Sci Rep 2019;9:4521. [PMID: 30872777 DOI: 10.1038/s41598-019-41153-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
4 Tian XJ, Zhou D, Fu H, Zhang R, Wang X, Huang S, Liu Y, Xing J. Sequential Wnt Agonist Then Antagonist Treatment Accelerates Tissue Repair and Minimizes Fibrosis. iScience 2020;23:101047. [PMID: 32339988 DOI: 10.1016/j.isci.2020.101047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Ji X, Wu B, Han R, Yang J, Ayaaba E, Wang T, Han L, Ni C. The association of LAMB1 polymorphism and expression changes with the risk of coal workers' pneumoconiosis. Environ Toxicol 2017;32:2182-90. [PMID: 28444932 DOI: 10.1002/tox.22431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Wallace HJ, Cadby G, Melton PE, Wood FM, Falder S, Crowe MM, Martin LJ, Marlow K, Ward SV, Fear MW. Genetic influence on scar height and pliability after burn injury in individuals of European ancestry: A prospective cohort study. Burns 2019;45:567-78. [PMID: 30595539 DOI: 10.1016/j.burns.2018.10.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Ulukan B, Sila Ozkaya Y, Zeybel M. Advances in the epigenetics of fibroblast biology and fibrotic diseases. Current Opinion in Pharmacology 2019;49:102-9. [DOI: 10.1016/j.coph.2019.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sisto M, Ribatti D, Lisi S. SMADS-Mediate Molecular Mechanisms in Sjögren's Syndrome. Int J Mol Sci 2021;22:3203. [PMID: 33801157 DOI: 10.3390/ijms22063203] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Soffritti I, D'Accolti M, Ravegnini G, Arcangeletti MC, Maccari C, De Conto F, Calderaro A, Caselli E. Modulation of microRNome by Human Cytomegalovirus and Human Herpesvirus 6 Infection in Human Dermal Fibroblasts: Possible Significance in the Induction of Fibrosis in Systemic Sclerosis. Cells 2021;10:1060. [PMID: 33946985 DOI: 10.3390/cells10051060] [Cited by in F6Publishing: 1] [Reference Citation Analysis]